Cleared Traditional

K973502 - IMPLANTECH CONFORM BINDER SUBMALAR IMPLANT

K973502 is an FDA 510(k) clearance for IMPLANTECH CONFORM BINDER SUBMALAR IMPLANT, manufactured by Implantech Associates, Inc.. The device is a Class 2 General & Plastic Surgery device with product code LZK cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K973502 · Implantech Associates, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
52d
Days
Class 2
Risk

K973502 is an FDA 510(k) clearance for the IMPLANTECH CONFORM BINDER SUBMALAR IMPLANT. Classified as Implant, Malar (product code LZK), Class II - Special Controls.

Submitted by Implantech Associates, Inc. (Washington, US). The FDA issued a Cleared decision on November 7, 1997 after a review of 52 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3550 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Implantech Associates, Inc. devices

FDA 510(k) Submission Details - K973502

510(k) Number K973502 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 1997
Decision Date November 07, 1997
Days to Decision 52 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 115d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZK Device Classification - Class 2, Special Controls

Product Code LZK Implant, Malar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - LZK Implant, Malar

All 32
Devices cleared under the same product code (LZK) and FDA review panel - the closest regulatory comparables to K973502.
SPECTRUM DESIGNS PROFILE MALAR IMPLANT
K980139 · Spectrum Designs, Inc. · Mar 1998
SPECTRUM DESIGNS MEDIAL MALAR IMPLANT
K980140 · Spectrum Designs, Inc. · Mar 1998
SPECTRUM DESIGNS PROJECTION MALAR IMPLANT
K980141 · Spectrum Designs, Inc. · Mar 1998
DURALASTIC ANATOMICAL MALAR IMPLANT
K973574 · Hanson Medical, Inc. · Oct 1997
DURALASTIC ANATOMICAL MALAR IMPLANTS
K971479 · Allied Biomedical Corp. · Jul 1997
BONE SOURCE HYDROXYAPATITE
K970400 · Orthofix, Inc. · May 1997